Drug Target Review2023-10-26T16:00:23
Researchers have found that reducing glycosylation on the T cell surface may offer new approaches to cancer immunotherapy.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2025-10-22T14:00:00
Sponsored by Wuxi Biologics
2026-07-31T06:00:00
Contributor Dr Davinder Ramsingh, Drug Target Review
2025-06-11T14:00:00
Sponsored by Eurofins Discovery
2026-03-11T14:00:00
Sponsored by Merck
2023-11-24T12:06:45
Sponsored by Quantum-Si
2026-05-22T07:38:00
Contributor Dr Helen Bright, Drug Target Review
Site powered by Webvision Cloud